Ultragenyx Pharmaceutical...
(RARE)
undefined
undefined%
At close: undefined
43.60
2.30%
Pre-market Jan 07, 2025, 06:41 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -5.8 | -4.58 | -12.56 | -45.15 | -6 | -10.95 | -6.52 | -11.32 | -28.34 | -21.1 | -35.01 | -59.65 | -142.27 |
| PS Ratio | 8.10 | 8.92 | 16.22 | 31.08 | 23.30 | 42.03 | 753.82 | 20.93K | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 12.77 | 9.19 | 6.18 | 7.30 | 3.70 | 3.55 | 5.13 | 5.87 | 7.77 | 6.82 | 24.50 | 11.55 | 91.55 |
| P/FCF Ratio | -6.74 | -6.15 | -13.84 | -47.82 | -6.53 | -7.35 | -7.67 | -16.26 | -37.2 | -26.97 | -38.85 | -71.67 | -152.9 |
| P/OCF Ratio | -7.41 | -8.51 | -16.83 | -63.7 | -7 | -7.45 | -7.76 | -17.29 | -38.94 | -28.27 | -39.35 | -77.93 | -167.28 |
| OCF/S Ratio | -1.09 | -1.05 | -0.96 | -0.49 | -3.33 | -5.64 | -97.18 | -1.21K | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | 0.03 | 0.39 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 2.49 | 3.28 | 4.63 | 6.76 | 8.13 | 6.90 | 3.43 | 8.27 | 16.13 | 14.98 | 9.33 | 27.12 | 10.96 |
| Current Ratio | 2.61 | 3.38 | 4.72 | 6.83 | 8.24 | 6.99 | 3.44 | 8.27 | 16.13 | 14.98 | 9.33 | 27.12 | 10.96 |
| Asset Turnover | 0.29 | 0.24 | 0.23 | 0.15 | 0.09 | 0.07 | 0.01 | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -8.62 | -15.09 | -12.97 | -9.92 | -373.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.3 |
| Return on Equity (ROE) | -2.2 | -2.01 | -0.49 | -0.16 | -0.62 | -0.32 | -0.79 | -0.52 | -0.27 | -0.32 | -0.7 | -0.19 | -0.64 |
| Return on Assets (ROA) | -0.41 | -0.46 | -0.3 | -0.11 | -0.35 | -0.27 | -0.62 | -0.45 | -0.26 | -0.3 | -0.59 | -0.18 | -0.56 |
| Return on Capital (ROIC) | -0.47 | -0.51 | -0.28 | -0.21 | -0.41 | -0.58 | -0.78 | -0.52 | -0.28 | -0.31 | -0.6 | -0.19 | -0.59 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.07 | n/a | n/a | n/a |
| Gross Profit Margin | 89.59% | 92.21% | 95.44% | 97.74% | 91.31% | 97.77% | 99.96% | -137.65K% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -139.7% | -194.71% | -129.2% | -68.84% | -388.31% | -383.75% | -11.57K% | -184.87K% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -140.12% | -193.14% | -128.91% | -68.39% | -385.14% | -382.75% | -12.19K% | -184.84K% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -131.08% | -178.6% | -108.63% | -121.8% | -408.98% | -721.18% | -12.59K% | -186.47K% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -120.11% | -144.93% | -117.18% | -64.98% | -356.96% | -572.18% | -9.83K% | -128.69K% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -118.93% | -176.29% | -116.77% | -51.58% | -375.81% | -344.81% | -11.96K% | -183.90K% | n/a | n/a | n/a | n/a | n/a |